IPT-weighted cumulative incidence and SHRs in the intention-to-treat analysis for factor Xa inhibitor cohort versus the dabigatran cohort during 5 years of follow-up.
Background Implementing a prognostic model in clinical practice requires assessing not just its accuracy but also how it may impact patient and healthcare outcomes. Evaluating these impacts requires c
